Therapeutic indications
Indicated in the treatment of intestinal parasitoses of horses, not intended for the production of food for human consumption, caused by large and small strongyles (strongylus vulgaris, s. Equinus, trichonema spp., Triodentophorus spp.), roundworms (parascaris centorum), pinworms (oxyuris equis) and tapeworms (anoplocephala perfoliata).
Dosage and administration
The product must be administered orally, mixing it with the usual food ration and checking that it is completely consumed. Use the packaging most suited to the needs of the treatment to be carried out. Administer at a rate of 40 mg of product (equal to 6.733 mg of active ingredient) per kg of live weight of the animal. For foals aged between two and eight months, administration is carried out every 4-6 weeks. In adult horses, administration is carried out 3-4 days before being put out to pasture. In risk conditions, administer every 4 weeks. In mares, administer 1-2 weeks before giving birth, then repeat 1-2 weeks after giving birth, subsequently every 6-8 weeks. In the case of infestations caused by tapeworms (flatworms), the doses should be doubled: in the case of particularly serious infestations, repeat the treatment after 20 days.
Contraindications
Pyrantel pamoate has a safety coefficient equal to 20 times the pharmacologically active dose; its use is not recommended in severely debilitated subjects due to its pharmacological action (nicotinic activity), which is particularly pronounced in such subjects; it can be safely administered to pregnant mares, foals, stallions and competition horses even during competitions and training periods; It does not have any teratogenic effect at any stage of pregnancy.
Excipients
1 g of powder contains: lactose 514.583 mg.
Target species
Equines